(HealthDay)—Incretin treatment appears to improve non-ST-elevation myocardial infarction (NSTEMI) outcomes in patients with type 2 diabetes and non-obstructive coronary artery stenosis (NOCS), according to a study published ...
Oct 29, 2017
0
0
New research presented at ESC Congress today suggests that for acute coronary syndrome (ACS) patients who require percutaneous coronary intervention (PCI), treatment according to contemporary guidelines for dual anti-platelet ...
Aug 29, 2017
0
0
Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of patients' risk for acute coronary syndrome (ACS), which includes heart attack, in patients of different gender ...
Jun 23, 2017
0
0
Complications of pregnancy, such as high blood pressure and infections, are linked to a heightened risk of early coronary heart disease in the young adult offspring, finds research published in the online journal Heart Asia.
May 24, 2017
0
2
In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death, myocardial infarction ...
May 17, 2017
0
0
(HealthDay)—For acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel, prasugrel, or ticagrelor, ischemic outcome does not differ by gender, according to a ...
May 4, 2017
0
0
(HealthDay)—For adults presenting to the emergency department with chest pain, a single high-sensitivity assay for cardiac troponin T (hs-cTnT) below the limit of detection and a non-ischemic electrocardiogram (ECG) can ...
Apr 19, 2017
0
0
High-sensitivity assays for cardiac troponin T can quickly and safely rule out myocardial infarction (MI) in patients presenting to emergency departments (ED) with possible emergency acute coronary syndrome. A single troponin ...
Apr 17, 2017
0
0
(HealthDay)—An early invasive strategy has no benefit for reducing the 10-year composite outcomes of death or spontaneous myocardial infarction (MI) for patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) ...
Apr 17, 2017
0
0
Patients with acute coronary syndrome who were treated with the blood-thinning drug rivaroxaban in addition to an antiplatelet medication (clopidogrel or ticagrelor) experienced no increase in bleeding complications compared ...
Mar 20, 2017
0
0
